Suchergebnisse - "Bajel, Ashish"

PubPharm (3)

1

A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes

enthalten in: American journal of hematology | 2023

von Zeidan, A. | Borate, U. | Pollyea, D. | +16

2

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

enthalten in: Cancer discovery | 2021

von Pullarkat, V. | Lacayo, N. | Jabbour, E. | +26

CommentIn: Cancer Discov. 2021 Jun;11(6):1324-1326. - PMID 34078661

3

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

enthalten in: Blood | 2021

von Thijssen, R. | Diepstraten, S. | Moujalled, D. | +33

CommentIn: Blood. 2021 May 20;137(20):2711-2712. - PMID 34014291

1
[1]